Could a DNA-Digesting enzyme help fight sepsis? early trial launches
NCT ID NCT05453695
First seen Mar 16, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This early-stage study tests a drug called DNase I given through a vein to 36 ICU patients with sepsis. The main goal is to check if the drug is safe and feasible to give in this setting. Researchers will also track how patients' organ function changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hamilton Health Sciences
RECRUITINGHamilton, Ontario, L8L 0A4, Canada
Contact
Conditions
Explore the condition pages connected to this study.